Mesa Labs Announces Changes in The Composition of Its Board of Directors Lakewood, Colorado, March 06, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) has announced several changes to the composition of its Board of Directors (the “Board”). As previously announced, on January 23, 2019 David B. Perez was appointed…
DetailsLakewood, Colorado, February 4, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income for the third quarter ended December 31, 2018. In comparison to the same quarter in the prior year, third quarter revenues increased 13 percent to $26,682,000, operating income increased 113…
DetailsLakewood, Colorado, July 9, 2018 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 17, 2018, to shareholders of record at the close of business…
DetailsMay 16, 2018, Lakewood, Colorado – A recent study from Taiwan determined that kidney failure patients that begin seeing a nephrologist early on before starting dialysis may help prevent major cardiovascular events. Of more than 60,000 patients reviewed, all of them received pre-dialysis care in some way. Forty percent had early, frequent visits, 21% with…
Details
